Solid Form Patents: Part I – Introduction and Laying the Genus/Species Foundation
Read More

Using Solid Form Patents to Protect Pharmaceutical Products — Part I

Read More

Using Solid Form Patents to Protect Pharmaceutical Products — Part II

Read More


IP Watchdog Life Sciences Patent Masters Program
October 25th - October 26th, 2022
Dulles, VA
Eyal Barash will be a featured panelist at IP Watchdog's first annual Life Sciences Masters program. Eyal will be joined by Debora Plehn-Dujowich of Eckert Seamans Cherin & Melliot LLC and will be discussing strategic considerations for life sciences claim drafting.
Registration and Conference
10th Annual Drug Repurposing and Repositioning Conference
November 14th - November 15th
Washington D.C.
Eyal Barash will be returning to the Drug Repositioning Conference as a featured speaker. He will be discussing the strategy of deploying new small-molecule solid form drug substance patents for drug repurposing.
Registration and Conference Info


What is a solid form?

A solid form is the solid representation of a chemical compound.  Examples include polymorphs, salts, solvates, hydrates, cocrystals, and amorphous solids.

Why patent solid forms?

Solid forms are compositions of matter and Orange-Book listable as drug substance.  When the science is right, patenting follows.

How do you patent a solid form?

The same rules apply to solid forms as to any other inventions.  Careful attention should be paid to the kinds and quality of data used in solid form patents.


pharmaceutical patents

Orange-Book Listable Patents Add Value


Intellectual Property as Deal Currency

ip strategy and execution

A Strategy Requires a Realistic Plan


Legal Functionality as a Business Driver
This is some text inside of a div block.